BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24586174)

  • 1. Implication of PMLIV in both intrinsic and innate immunity.
    El Asmi F; Maroui MA; Dutrieux J; Blondel D; Nisole S; Chelbi-Alix MK
    PLoS Pathog; 2014 Feb; 10(2):e1003975. PubMed ID: 24586174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to rabies virus infection conferred by the PMLIV isoform.
    Blondel D; Kheddache S; Lahaye X; Dianoux L; Chelbi-Alix MK
    J Virol; 2010 Oct; 84(20):10719-26. PubMed ID: 20702643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.
    Maroui MA; Pampin M; Chelbi-Alix MK
    J Virol; 2011 Dec; 85(24):13164-73. PubMed ID: 21994459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Implication of PML nuclear bodies in intrinsic and innate immunity].
    Maroui MA; El Asmi F; Dutrieux J; Chelbi-Alix MK; Nisole S
    Med Sci (Paris); 2014; 30(8-9):765-71. PubMed ID: 25174753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML positively regulates interferon gamma signaling.
    El Bougrini J; Dianoux L; Chelbi-Alix MK
    Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.
    Maroui MA; Maarifi G; McManus FP; Lamoliatte F; Thibault P; Chelbi-Alix MK
    Mol Cell Proteomics; 2018 Jun; 17(6):1196-1208. PubMed ID: 29535160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
    Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
    PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β induces PML SUMOylation, degradation and PML nuclear body disruption.
    El-Asmi F; El-Mchichi B; Maroui MA; Dianoux L; Chelbi-Alix MK
    Cytokine; 2019 Aug; 120():264-272. PubMed ID: 31153006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3C protease of enterovirus 71 cleaves promyelocytic leukemia protein and impairs PML-NBs production.
    Li Z; Wu Y; Li H; Li W; Tan J; Qiao W
    Virol J; 2021 Dec; 18(1):255. PubMed ID: 34930370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I IFN-Inducible Downregulation of MicroRNA-27a Feedback Inhibits Antiviral Innate Response by Upregulating Siglec1/TRIM27.
    Zheng Q; Hou J; Zhou Y; Yang Y; Cao X
    J Immunol; 2016 Feb; 196(3):1317-26. PubMed ID: 26700765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
    Chen Y; Wright J; Meng X; Leppard KN
    Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sp100 isoform-specific regulation of human adenovirus 5 gene expression.
    Berscheminski J; Wimmer P; Brun J; Ip WH; Groitl P; Horlacher T; Jaffray E; Hay RT; Dobner T; Schreiner S
    J Virol; 2014 Jun; 88(11):6076-92. PubMed ID: 24623443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKɛ-mediated phosphorylation.
    Wang S; Xie F; Chu F; Zhang Z; Yang B; Dai T; Gao L; Wang L; Ling L; Jia J; van Dam H; Jin J; Zhang L; Zhou F
    Nat Immunol; 2017 Jul; 18(7):733-743. PubMed ID: 28481329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion.
    Masroori N; Merindol N; Berthoux L
    Retrovirology; 2016 Mar; 13():19. PubMed ID: 27000403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promyelocytic Leukemia Restricts Enterovirus 71 Replication by Inhibiting Autophagy.
    Chen D; Feng C; Tian X; Zheng N; Wu Z
    Front Immunol; 2018; 9():1268. PubMed ID: 29922292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.
    Chelbi-Alix MK; Quignon F; Pelicano L; Koken MH; de Thé H
    J Virol; 1998 Feb; 72(2):1043-51. PubMed ID: 9444998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses.
    Scherer M; Otto V; Stump JD; Klingl S; Müller R; Reuter N; Muller YA; Sticht H; Stamminger T
    J Virol; 2016 Feb; 90(3):1190-205. PubMed ID: 26559840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
    Maarifi G; Hannoun Z; Geoffroy MC; El Asmi F; Zarrouk K; Nisole S; Blondel D; Chelbi-Alix MK
    J Virol; 2016 Jul; 90(14):6598-6610. PubMed ID: 27170750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of promyelocytic leukemia protein on virus-host balance.
    Bonilla WV; Pinschewer DD; Klenerman P; Rousson V; Gaboli M; Pandolfi PP; Zinkernagel RM; Salvato MS; Hengartner H
    J Virol; 2002 Apr; 76(8):3810-8. PubMed ID: 11907221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.